Predictors of 15-year survival among Australian women with diabetes from age 76-81.


Journal

Diabetes research and clinical practice
ISSN: 1872-8227
Titre abrégé: Diabetes Res Clin Pract
Pays: Ireland
ID NLM: 8508335

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 06 11 2018
revised: 06 02 2019
accepted: 15 02 2019
pubmed: 27 2 2019
medline: 10 7 2019
entrez: 27 2 2019
Statut: ppublish

Résumé

To assess the impact of diabetes on the survival of older women, adjusted for other all-cause mortality predictors. Data were used from the 1921-26 cohort of the Australian Longitudinal Study on Women's Health, when the women were aged 76-81 years at baseline, with linkage to the National Death Index. Survival curves were plotted to compare the survival of women with no diabetes, incident diabetes and prevalent diabetes over 15 years. Cox proportional hazards models were used to examine the association between diabetes and all-cause mortality risks. A total of 972 (11.7%) of 8296 eligible women reported either incident, 522 (6.3%) or prevalent, 450 (5.4%) diabetes. The median survival times were 10.1, 11.4 and 12.7 years among women with prevalent, incident and no diabetes, respectively. The risks of death were 30% [HR: 1.30 (95% CI: 1.16-1.45)] and 73% [HR: 1.73 (CI: 1.57-1.92)] higher for women with incident and prevalent diabetes compared to women without diabetes. These associations were sustained after controlling for demographics, body mass index, smoking status, comorbidities and health care use. This study revealed that diabetes is associated with reduced survival probabilities for older women with minimal moderation after adjustment for other predictors. Our findings suggest that diabetes management guidelines for older women need to integrate factors such as comorbidities, smoking and being underweight to reduce the risk of mortality.

Identifiants

pubmed: 30807777
pii: S0168-8227(18)31543-2
doi: 10.1016/j.diabres.2019.02.016
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

48-56

Informations de copyright

Crown Copyright © 2019. Published by Elsevier B.V. All rights reserved.

Auteurs

Befikadu L Wubishet (BL)

Research Centre for Generational Health and Ageing, University of Newcastle, Newcastle, NSW, Australia; Department of Pharmacy, Mekelle University, Mekelle, Tigray, Ethiopia. Electronic address: BefikaduLegesse.Wubishet@uon.edu.au.

Melissa L Harris (ML)

Research Centre for Generational Health and Ageing, University of Newcastle, Newcastle, NSW, Australia.

Peta M Forder (PM)

Research Centre for Generational Health and Ageing, University of Newcastle, Newcastle, NSW, Australia.

Shamasunder H Acharya (SH)

John Hunter Hospital, Newcastle, NSW, Australia.

Julie E Byles (JE)

Research Centre for Generational Health and Ageing, University of Newcastle, Newcastle, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH